These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15482410)

  • 1. Factors that influence spontaneous reporting of adverse drug reactions: a model centralized in the medical professional.
    Herdeiro MT; Polonia J; Gestal-Otero JJ; Figueiras A
    J Eval Clin Pract; 2004 Nov; 10(4):483-9. PubMed ID: 15482410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on the knowledge and attitude to adverse drug reactions reporting among healthcare professionals in Wuhan city].
    Li Q; Zhang SM; Chen HT; Fang SP; Yu X; Liu D; Shi LY; Zeng FD
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Oct; 25(10):894-7. PubMed ID: 15631751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia.
    Aziz Z; Siang TC; Badarudin NS
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):223-8. PubMed ID: 16947117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions.
    Li Q; Zhang SM; Chen HT; Fang SP; Yu X; Liu D; Shi LY; Zeng FD
    Chin Med J (Engl); 2004 Jun; 117(6):856-61. PubMed ID: 15198887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reactions reporting by physicians in Ibadan, Nigeria.
    Okezie EO; Olufunmilayo F
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):517-22. PubMed ID: 18404621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers.
    Fleuranceau-Morel P
    Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system.
    Ortega A; Aguinagalde A; Lacasa C; Aquerreta I; Fernández-Benítez M; Fernández LM
    Ann Pharmacother; 2008 Oct; 42(10):1491-6. PubMed ID: 18780808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway.
    Granas AG; Buajordet M; Stenberg-Nilsen H; Harg P; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):429-34. PubMed ID: 16953518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lack of knowledge about the voluntary reporting system of adverse drug reactions as a major cause of underreporting: direct survey among health professionals.
    Pérez García M; Figueras A
    Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1295-302. PubMed ID: 21793098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reactions of antidepressants and antipsychotics: experience, knowledge and attitudes among Norwegian psychiatrists.
    Castberg I; Reimers A; Sandvik P; Aamo TO; Spigset O
    Nord J Psychiatry; 2006; 60(3):227-33. PubMed ID: 16720514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge and attitudes of physicians relating to reporting of adverse drug reactions in Sokoto, north-western Nigeria.
    Bello SO; Umar MT
    Ann Afr Med; 2011; 10(1):13-8. PubMed ID: 21311149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reaction monitoring: knowledge, attitude and practices of medical students and prescribers.
    Rehan HS; Vasudev K; Tripathi CD
    Natl Med J India; 2002; 15(1):24-6. PubMed ID: 11855588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under-reporting on odds ratios.
    van der Heijden PG; van Puijenbroek EP; van Buuren S; van der Hofstede JW
    Stat Med; 2002 Jul; 21(14):2027-44. PubMed ID: 12111885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of physicians' attitudes on under-notifying infectious diseases: a longitudinal study.
    Figueiras A; Lado E; Fernández S; Hervada X
    Public Health; 2004 Oct; 118(7):521-6. PubMed ID: 15351226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge, attitude and practices associated with adverse drug reaction reporting amongst doctors in a teaching hospital.
    Chopra D; Wardhan N; Rehan HS
    Int J Risk Saf Med; 2011; 23(4):227-32. PubMed ID: 22156087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions reporting at a referral hospital in Zimbabwe.
    Khoza S; Madungwe I; Nyambayo P; Mthethwa J; Chikuni O
    Cent Afr J Med; 2004; 50(11-12):104-7. PubMed ID: 16615658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicians' attitudes and adverse drug reaction reporting : a case-control study in Portugal.
    Herdeiro MT; Figueiras A; Polónia J; Gestal-Otero JJ
    Drug Saf; 2005; 28(9):825-33. PubMed ID: 16119975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reporting of side-effects--a system in need of improvement. Reporting of a physician questionnaire].
    Ekbom Y; Hedenmalm K; Dalin L; Lönnroth K; Persson I
    Lakartidningen; 2002 Aug; 99(34):3290-5. PubMed ID: 12362847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.
    Blenkinsopp A; Wilkie P; Wang M; Routledge PA
    Br J Clin Pharmacol; 2007 Feb; 63(2):148-56. PubMed ID: 17274788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.